Unknown

Dataset Information

Efficacy and Safety of Mineralocorticoid Receptor Antagonists in Kidney Failure Patients Treated with Dialysis: A Systematic Review and Meta-Analysis.


ABSTRACT:

Background and objectives

Patients with kidney failure have a high risk of cardiovascular disease due to cardiac remodeling, left ventricular fibrosis, and hyperaldosteronism, all of which can be potentially mitigated by mineralocorticoid receptor antagonists. However, because of the fear of hyperkalemia, the use of mineralocorticoid receptor antagonists in patients with kidney failure is limited in current clinical practice, and few studies have investigated the efficacy and safety. Thus, we aimed to determine the benefits and side effects of mineralocorticoid receptor antagonists in patients with kidney failure treated with dialysis.

Design, setting, participants, & measurements

This is a systematic review and meta-analysis of randomized controlled trials published from 20

SUBMITTER: Chen KT 

PROVIDER: S-EPMC8216612 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature